Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/15/2003US20030092130 DNA encoding polypeptides having interferon-gamma inducing activity
05/15/2003US20030092129 Nervous system polypeptide for use in the treatment of nervous system disorders
05/15/2003US20030092128 Nucleotide squences coding polypeptide for use in the textile and fabric treatment
05/15/2003US20030092127 Nucleotide sequences coding polypeptides for use in the treatment of asthma, parkinson's, heart, hypotensive and urogenital disorders
05/15/2003US20030092126 Fragments of leptin (ob protein)
05/15/2003US20030092124 Protein for use in the development of insecticide and insecticide targets
05/15/2003US20030092123 Polypeptide for use in the treatment of cancer, immunological and inflammatory disorders
05/15/2003US20030092122 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092121 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092120 Novel human K+ ion channel and therapeutic applications thereof
05/15/2003US20030092119 Nuclear hormone receptors
05/15/2003US20030092117 Zalpha13: a human secreted protein
05/15/2003US20030092116 Nucleotide sequences coding polypeptide for use in the treatment modulation and diagnosis spleen, gastrointestinal, leukemic, urogenital and thrombotic disorders
05/15/2003US20030092115 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092113 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092112 Novel nucleic acids and polypeptides
05/15/2003US20030092111 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092110 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092109 Composition for use in the prevention of diarrhea and the diagnosis of malaria
05/15/2003US20030092108 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092107 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092106 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092105 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092104 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092103 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092102 Nucleic acids, proteins, and antibodies
05/15/2003US20030092101 Human tumor necrosis factor receptors TR13 and TR14
05/15/2003US20030092099 Genetic engineering; for production of enzymes, growth factors, cytokines, immunogenic proteins, and immunoglobulin proteins
05/15/2003US20030092098 Nucleotide sequences coding polypeptide for use as diagnostc tools in genetic engineering
05/15/2003US20030092094 Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies
05/15/2003US20030092087 Ehrlichia disulfide bond formation proteins and uses thereof
05/15/2003US20030092084 EBV-infected stomach cancer cell line
05/15/2003US20030092083 Protein for use in the treatment of tumor disorders
05/15/2003US20030092080 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
05/15/2003US20030092079 Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactions
05/15/2003US20030092077 Chemotactic peptide for use in the diagnosis and treatment of reproductive disorders
05/15/2003US20030092070 Genetic construct intracellular monitoring system
05/15/2003US20030092069 Hollow nanoparticle for use in the transfer of biopolymer into cells
05/15/2003US20030092066 Purified Stat proteins and methods of purifying thereof
05/15/2003US20030092063 Nucleotide sequences coding polypeptide for use in the treatment of cancer and diabetes
05/15/2003US20030092061 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferation and tumor disorders
05/15/2003US20030092054 Protein complexes and assays for screening anti-cancer agents
05/15/2003US20030092049 Regulation of nf-at interacting protein nip 45 variant
05/15/2003US20030092048 Nucleotide squences coding polypeptide for use in the diagnosis, prevention and treatment of liver, nervous system, inflammatory and kidney disorders
05/15/2003US20030092044 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders
05/15/2003US20030092043 Melanoma differentiation associated gene - 5 and promoter and uses thereof
05/15/2003US20030092042 Diagnosing cancer in mammals; obtain tissue sample, extract nucleotide sequences, detect galinin gene, determine copy number for gene, compare to control, amplified copy number indicates cancer
05/15/2003US20030092038 Genes for Niemann-Pick type C disease
05/15/2003US20030092035 Nucleotide sequences coding polypeptide for use in the treatment of pain
05/15/2003US20030092032 Reporter gene construct for the detection of HIV Rev and HIV Tat
05/15/2003US20030092030 Wit 3.0, a novel gene to control soft tissue wound healing
05/15/2003US20030092026 Nucleotide sequences coding polypeptide for use biosynthesis of methionine; for use in preparation of animal feeds
05/15/2003US20030092025 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment, prevention of tumor disorders
05/15/2003US20030092024 Essential bacterial genes and their use
05/15/2003US20030092023 Adjustment of nucleotide sequences; obtain nucleotide sequences, fragment, incubate with templates, propagate recover nuceotide sequences
05/15/2003US20030092019 Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
05/15/2003US20030092017 Polynucleotide encoding a novel immunoglobulin superfamily member, APEX4, and variants and splice variants thereof
05/15/2003US20030092014 Nucleotide sequences coding polypeptide for use in the generation of stress, disease and drought resistant plants
05/15/2003US20030092011 Human cDNAs and proteins and uses thereof
05/15/2003US20030092010 Regulation of gene expression in cells; obtain cells, transform with vector coding preferential genes, incubate cells with ligand, monitor reporter gene expression, monitor formation of binding complexes
05/15/2003US20030092004 Excitatory glycine receptors and methods
05/15/2003US20030092002 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092000 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
05/15/2003US20030091996 Apoptin-associating protein
05/15/2003US20030091992 Nutrients broth for use in the cytological and molecular analysis
05/15/2003US20030091985 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
05/15/2003US20030091984 Methods for judging resistance to the onset of bovine leukemia
05/15/2003US20030091983 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/15/2003US20030091981 Kit for use in the deetction of genes associated with xylogenesis
05/15/2003US20030091976 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
05/15/2003US20030091973 Method of identifying osteoregenerative agents using differential gene expression
05/15/2003US20030091598 Compounds and methods for the diagnosis and treatment of Babesia infection
05/15/2003US20030091597 Genetic engineering; screening for tuberculosis
05/15/2003US20030091594 CD4-independent HIV envelope proteins as vaccines and therapeutics
05/15/2003US20030091592 Inducting immunology response
05/15/2003US20030091591 Parasiticides; veterinary medicine
05/15/2003US20030091590 Recombinant rhabdoviruses as live-viral vaccines
05/15/2003US20030091588 Ehrlichia chaffeensis 28 kDa outer membrane protein multigene family
05/15/2003US20030091586 Fish immunoglobulin
05/15/2003US20030091585 Vaccine composition containing a promoter peptide
05/15/2003US20030091583 Use of mia in immunotheraphy
05/15/2003US20030091582 Autoimmune diseases; antitumor agents; antiallergens
05/15/2003US20030091580 Compositions and methods for the therapy and diagnosis of ovarian cancer
05/15/2003US20030091577 Streptococcus pneumoniae proteins and nucleic acid molecules
05/15/2003US20030091576 Therapy, prevention vascular system diseases; administering fusion protein; cardiovascular disorders
05/15/2003US20030091575 Activation immunology response; administering fusion protein
05/15/2003US20030091571 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/15/2003US20030091569 Methods for the treatment of carcinoma
05/15/2003US20030091567 Antiinflammatory agents; anticancer agents
05/15/2003US20030091565 Binding polypeptides and methods based thereon
05/15/2003US20030091564 Methods of treating an undesired immune response by blocking the binding 0f cd40 ligand to cd40
05/15/2003US20030091563 Novel GPCR-proteins and nucleic acids encoding same
05/15/2003US20030091562 Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
05/15/2003US20030091559 Biocompatibility; liquid phase
05/15/2003US20030091556 Methods of inhibiting tumor growth and angiogenesis with anastellin
05/15/2003US20030091551 Tyrosone kinase as insulin receptor; antidiabetic agents
05/15/2003US20030091550 Novel strains of bacillus thuringiensis and pesticidal composition comprising them
05/15/2003US20030091547 Antiischemic agents; administering endothelial cells, bone marrow culture
05/15/2003US20030091545 Insoluble collagen matrix containing cells, microspheresc and promoters
05/15/2003US20030091543 Therapeutic cell preparation grafts and methods of use thereof
1 ... 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 ... 2916